Published in Surgery on July 01, 1971
Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis. Ann Surg (1973) 2.47
The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg (1984) 1.92
The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models. Ann Surg (1985) 1.42
Pancreatitis--a retrospective study. Gut (1976) 1.33
Diagnosis and management of acute pancreatitis. Ann R Coll Surg Engl (1974) 1.11
Inhibition of serum and urine amylase activity in pancreatitis with hyperlipemia. Ann Surg (1975) 1.10
Antecedent long term ethanol consumption in combination with different diets alters the severity of experimental acute pancreatitis in rats. Gut (1987) 0.81
Respiratory failure in acute pancreatitis: a possible role for triglycerides. Ann Surg (1979) 0.81
Impaired lipid clearance in patients with previous acute pancreatitis. Gut (1985) 0.79
Clinical Study of 224 Patients with Hypertriglyceridemia Pancreatitis. Chin Med J (Engl) (2015) 0.79
Letter: Hypertriglyceridaemia and abdominal pain. Br Med J (1976) 0.77
Acute pancreatitis. Calif Med (1972) 0.76
Possible mechanisms of normal amylase activity in hyperlipemic pancreatitis. Can Med Assoc J (1976) 0.75
Detrimental impact of hyperlipidemia on the peripheral nervous system: A novel target of medical epidemiological and fundamental research study. Neural Regen Res (2012) 0.75
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg (1997) 8.86
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg (2001) 8.34
The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg (1995) 5.95
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66
Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg (1987) 5.58
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science (1968) 4.38
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg (1998) 4.19
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res (2001) 4.19
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90
Clinical prediction rule for pulmonary infiltrates. Ann Intern Med (1990) 3.81
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56
Early predictors of career achievement in academic medicine. JAMA (1992) 3.35
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol (2001) 3.27
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg (1993) 3.17
Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg (1996) 3.13
Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg (1999) 3.09
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg (2000) 2.94
Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91
Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg (1979) 2.90
Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg (2001) 2.80
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg (1998) 2.60
Chronic pancreatic ascites and pancreatic pleural effusions. Gastroenterology (1978) 2.60
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53
Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg (1997) 2.53
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res (2001) 2.50
Postoperative bile duct strictures: management and outcome in the 1990s. Ann Surg (2000) 2.50
Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis. Ann Surg (1973) 2.47
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Factors affecting mortality in biliary tract surgery. Am J Surg (1981) 2.41
Laparoscopic cholecystectomy-related bile duct injuries: a health and financial disaster. Ann Surg (1997) 2.41
Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg (1999) 2.37
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36
Measuring the quality of medical care: second revision of tables of indexes. N Engl J Med (1980) 2.34
Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33
Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg (1998) 2.32
Surgical management of unresectable carcinoma of the pancreas. Surgery (1982) 2.30
Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg (1995) 2.28
Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg (1993) 2.26
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25
Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg (1999) 2.23
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
Cecal volvulus: analysis of 50 patients with long-term follow-up. Ann Surg (1979) 2.13
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04
Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol (1988) 2.03
Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg (2000) 2.00
The clinical significance of retroperitoneal fibrosis. Surgery (1977) 1.99
Preoperative recognition of intestinal strangulation obstruction. Prospective evaluation of diagnostic capability. Am J Surg (1983) 1.99
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg (1984) 1.92
Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92
Factors influencing mortality in the treatment of pyogenic hepatic abscess. Surg Gynecol Obstet (1975) 1.91
Management of esophageal perforation. Am J Surg (1980) 1.90
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89
Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg (2000) 1.86
A gold foil electrode: extending the horizons for clinical electroretinography. Invest Ophthalmol Vis Sci (1979) 1.84
Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg (1998) 1.83
The natural history of pancreatic pseudocysts documented by computed tomography. Surg Gynecol Obstet (1990) 1.83
Internal pancreatic fistulas: pancreatic ascites and pleural effusions. Ann Surg (1976) 1.82
Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol (2000) 1.81
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81
Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol (1994) 1.79
Sclerosing cholangitis: biliary reconstruction with Silastic transhepatic stents. Surgery (1983) 1.77
Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg (1980) 1.75
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74
Acute pancreatitis with hyperlipemia: studies with an isolated perfused canine pancreas. Surgery (1977) 1.73
Reoperative surgery for periampullary adenocarcinoma. Arch Surg (1991) 1.73
Major bile duct injuries during laparoscopic cholecystectomy. Follow-up after combined surgical and radiologic management. Ann Surg (1997) 1.72
Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg (2002) 1.72
Benign postoperative biliary strictures. Operate or dilate? Ann Surg (1989) 1.71
Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71
DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol (1998) 1.71
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Current management of the Budd-Chiari syndrome. Ann Surg (1990) 1.68
Solid and papillary epithelial neoplasms of the pancreas. Surgery (1990) 1.68
Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg (1996) 1.67
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg (1999) 1.65